DUBAI, United Arab Emirates
Gulf Scientific Corporation (GSC), a prominent provider of laboratory solutions across analytical, material, and life sciences in the Gulf Cooperation Council (GCC), is excited to announce its recent agreement with R-Biopharm, a leading biotechnology company from Germany. This partnership, marks a significant step in expanding GSC’s portfolio in the fields of health, and quality of life through advanced biotechnological analysis. R-Biopharm, known for its dedication to consumer and patient health, aligns perfectly with GSC’s ethos. This collaboration aims to bring these high-value solutions to Saudi Arabia, under the analytical line of Gulf Scientific Corporation.
With a robust presence in major cities across the Gulf region, Gulf Scientific Corporation, along with its subsidiaries: Sama Masa, Dar Al-Aalmiyah, ATP Kuwait, JSC, and Atrium, continues its commitment to providing cutting-edge laboratory solutions. This new venture with R-Biopharm will further bolster GSC’s position as a leader in analytical and material sciences within the GCC.
Manaf Afyouni, Managing Director at Gulf Scientific Corporation, commented, “Our strategic alliance with R-Biopharm is a testament to our ongoing commitment to the scientific community. This partnership will enable us to offer comprehensive analytical solutions through Sama Masa, and Dar Al-Aalmiyah in Saudi Arabia, enhancing our portfolio and furthering our goal to contribute significantly to the scientific advancement and quality of life.”
The partnership between Gulf Scientific Corporation and R-Biopharm in Saudi Arabia is poised to set a new standard in the region’s analytical and biotechnology landscape, delivering top-tier biotechnological services and solutions.
